Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism [NA]
A completed study examining the effects of osteoprotegerin (OPG) and soluble RANKL on bone mineral density in individuals with primary hyper…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients
A completed clinical trial assessing the short- and long-term impact of subtotal parathyroidectomy on bone and mineral parameters in dialysi…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism [Phase 3]
Phase 3 trial comparing paricalcitol injections with maxacalcitol injections in adult Japanese CKD patients on hemodialysis with secondary h…
-
FDA approval · 2013-05-24FDA Approved: CALCITRIOL — Original Application (BIONPHARMA INC.)
FDA approved the original ANDA application for Calcitriol from BIONPHARMA INC., a generic version of the active vitamin D3 analog.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism [Phase 3]
This document notes the completion of the Phase 3 SENSOR trial evaluating cinacalcet for secondary hyperparathyroidism in patients on haemod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-05-15FDA Approved: CALCITRIOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for CALCITRIOL (calcitriol) from Sun Pharmaceutical Industries, Inc., updating the product’s reg…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) [Phase 2]
This completed Phase 2 trial evaluated the efficacy and safety of twice-daily cinacalcet (AMG 073) in patients with primary hyperparathyroid…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients [Phase 3]
This entry reports the completion of a Phase 3 study evaluating an investigational medication for secondary hyperparathyroidism in patients …
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis [Phase 3]
Phase 3 clinical trial of an investigational medication for secondary hyperparathyroidism in patients on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism [Phase 2]
A multicenter, open-label extension study of cinacalcet (AMG 073) assesses long-term safety and efficacy in individuals with primary hyperpa…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Oral Paricalcitol in Kidney Transplant Recipients [NA]
A completed clinical trial evaluated oral paricalcitol in kidney transplant recipients. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis [Phase 3]
A Phase 3 trial of cinacalcet HCl in chronic kidney disease patients with secondary hyperparathyroidism not on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer [Phase 4]
Amgen conducted a Phase 4 trial of an investigational medication for severe primary hyperparathyroidism and parathyroid neoplasms; the study…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
This update reports results from a completed clinical trial evaluating oral paricalcitol for predialysis chronic kidney disease patients, in…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism [Phase 2]
Phase 2 trial assessing paricalcitol's ability to lower parathyroid hormone levels and improve bone remodeling markers in renal transplant r…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism
This clinical trial update reports on non-specific symptoms and quality of life before and after surgery for mild primary hyperparathyroidis…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
This completed observational study evaluated the time to achieve the maintenance dose of paricalcitol (Zemplar) in patients with end-stage r…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism [NA]
A completed clinical trial comparing paricalcitol versus calcitriol for safety and efficacy in treating secondary hyperparathyroidism in pat…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation
A completed clinical trial evaluating morbidity related to secondary hyperparathyroidism in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
Completed update of a clinical trial evaluating mineral and bone disorders outcomes in Stage 5D chronic kidney disease (End-Stage Renal Dise…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Vitamin D Supplementation in HIV-infected Youth [Phase 2]
Phase 2 clinical trial evaluating Vitamin D (cholecalciferol) supplementation in HIV-infected youth with vitamin D deficiency has completed.
-
CLINICAL_TRIALS research · 2012-07-20Clinical Trial Update: Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
This clinical trial update investigates regulation of VDR, CaSR, cyclin D1, Ki67, and PCNA in primary hyperparathyroidism, with the study st…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Coexisting Thyroid Disease and Hyperparathyroidism
This completed clinical trial investigated the coexistence of thyroid disease and hyperparathyroidism, with hyperthyroidism listed as the co…
-
FDA approval · 2012-06-28FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved the supplemental application for Zemplar (paricalcitol) from AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D [Phase 4]
Phase 4 trial comparing paricalcitol to cinacalcet with low-dose vitamin D in patients with chronic kidney disease and secondary hyperparath…